- Featured Product
- KD/KO Validated
IRAK1 Polyclonal antibody
IRAK1 Polyclonal Antibody for FC, IF, IHC, IP, WB,ELISA
Cat no : 10478-2-AP
|Positive WB detected in||A549 cells, PC-13 cells, PC-12 cells, RAW 264.7 cells, HEK-293 cells, HeLa cells, Jurkat cells, K-562 cells, MCF-7 cells|
|Positive IP detected in||HeLa cells|
|Positive IHC detected in||human breast cancer tissue, human lung cancer tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in||HeLa cells|
|Positive FC detected in||HeLa cells|
|Western Blot (WB)||WB : 1:500-1:3000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:1000 for WB|
|Immunohistochemistry (IHC)||IHC : 1:50-1:500|
|Immunofluorescence (IF)||IF : 1:50-1:500|
|Sample-dependent, check data in validation data gallery|
10478-2-AP targets IRAK1 in WB, IP, IHC, IF, FC,ELISA applications and shows reactivity with human, mouse, rat samples.
|Tested Reactivity||human, mouse, rat|
|Cited Reactivity||human, mouse, rat, sheep|
|Host / Isotype||Rabbit / IgG|
|Immunogen||IRAK1 fusion protein Ag0728|
|Full Name||interleukin-1 receptor-associated kinase 1|
|Calculated molecular weight||77 kDa|
|Observed molecular weight||68-80 kDa|
|GenBank accession number||BC014963|
|Gene ID (NCBI)||3654|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
Interleukin-1 receptor-associated kinases (IRAKs) are a unique family of death domain containing protein kinases that play a key role in initiating innate immune response against foreign pathogens. They are involved in Toll-like receptor (TLR) and interleukin-1 receptor (IL-1R) signaling pathways. IRAK1 is the first member of this kinase family. Upon ligand binding to TLR/IL-1R, IRAK1 is recruited by MYD88 to the receptor-signaling complex, the association leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Hyper-phosphorylated IRAK1 then disengages from the receptor complex, and forms a cytosolic IRAK1-TRAF6 complex. TRAF6 then interacts with TAK and TAB, resulting in eventual activation of the NF-κB and MAPK pathways. Phosphorylated IRAK1 also undergoes ubiquitin-mediated degradation or sumoylation, which results in nuclear translocation and transcriptional activation of inflammatory target genes. (PMID: 17890055; 12620219)
|Product Specific Protocols|
|WB protocol for IRAK1 antibody 10478-2-AP||Download protocol|
|IHC protocol for IRAK1 antibody 10478-2-AP||Download protocol|
|IF protocol for IRAK1 antibody 10478-2-AP||Download protocol|
|IP protocol for IRAK1 antibody 10478-2-AP||Download protocol|
|FC protocol for IRAK1 antibody 10478-2-AP||Download protocol|
|Click here to view our Standard Protocols|
Mol Cell Proteomics
Quantification of dynamic protein interactions and phosphorylation in LPS signaling pathway by SWATH-MS.
Artif Cells Nanomed Biotechnol
Targeted delivery of microRNA 146b mimic to hepatocytes by lactosylated PDMAEMA nanoparticles for the treatment of NAFLD.
Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway.
Influence of the Total Saponin Fraction from Dioscorea nipponica Makino on TLR2/4-IL1R Receptor Singnal Pathway in Rats of Gouty Arthritis.
Sal B Alleviates Myocardial Ischemic Injury by Inhibiting TLR4 and the Priming Phase of NLRP3 Inflammasome.
Drug Des Devel Ther
Exosomes Derived from MicroRNA-146a-5p-Enriched Bone Marrow Mesenchymal Stem Cells Alleviate Intracerebral Hemorrhage by Inhibiting Neuronal Apoptosis and Microglial M1 Polarization.